Pinnacle Wealth Planning Services
AGMB icon

Pinnacle Wealth Planning Services’s AgomAb Therapeutics NV AGMB Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio AGMB Stock Details AGMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$821 Buy
+74
New +$957 ﹤0.01% 2637

Other funds holding AGMB

Andera Partners
Andera Partners Paris $176M AUM 1.8% 1-Year Est. Return
Crossmark Global Holdings
Crossmark Global Holdings Houston, Texas $7.69B AUM 31.68% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Pinnacle Wealth Planning Services's AGMB Position: Q3 2026 in Review

Pinnacle Wealth Planning Services opened a new position in AgomAb Therapeutics NV (AGMB) in Q3 2026: 74 shares worth $821. The stake represents ﹤0.01% of the portfolio and ranks #2637 among its holdings.

7 funds tracked by Wall St. Rank hold AGMB as of Q3 2026.

  • Pinnacle Wealth Planning Services held 74 shares of AgomAb Therapeutics NV worth $821 as of Q3 2026.
  • AgomAb Therapeutics NV was a new Pinnacle Wealth Planning Services position in Q3 2026.
  • AgomAb Therapeutics NV made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #2637 holding.
  • 7 funds tracked by Wall St. Rank held AgomAb Therapeutics NV as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.